List of Figures
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, G7 Countries (%), 2017* 14
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, E7 Countries (%), 2017* 17
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 19
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26
GlobalData Methodology 81


List of Tables
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Region, 2017* 7
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, G7 Countries (%), 2017* 14
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Juvenile Myelomonocytic Leukemia (JMML) to Oncology Clinical Trials, E7 Countries (%), 2017* 17
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Phase, 2017* 18
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 19
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Juvenile Myelomonocytic Leukemia (JMML) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26